Page 160 - Lab Tests News Today

Of the thousands of lives lost, and to bring an end to the emotional commemorations of the last few days. safety officials say the uk can expect more cases of e.coli in an outbreak that has already seen more than 100 people fall sick. tests are ongoing to find the source, but experts believe it is mostly likely to be linked to a widely available food product. our health reporter michelle roberts has more. most often, people catch e.coli from eating contaminated food. past outbreaks have been lin...

Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.

Confused by your pain? It might be coming from somewhere else! Referred pain travels along nerve pathways, causing pain in unexpected areas. Learn what pain in your arm, chest, or abdomen could mean. Dr. Reddy debunks myths and explains how doctors diagnose the true source of your pain.

India Business News: Healthcare costs cause stress, even for individuals who earn well and have full medical coverage.

Learn how to spot spurious drugs for cancer, hypertension, cholesterol, pediatric diseases. Find out why lab tests are necessary to identify fake and substandard medicines. Report suspected spurious drugs to the Telangana Drugs Control Administration.

NEW DELHI: A recent analysis of pathology tests conducted in the city's mohalla clinics between Feb and Dec last year has determined massive irregular.

Two private labs conducted 22 lakh tests in 2023, with 65,000 identified as fake. The government paid Rs 4.63 crore for these tests.

Seattle/King County Clinic returns to Seattle Center February 15-18, 2024, offering free dental, vision, and medical care to people in need. As healthcare costs continue to rise and public services dwindle, the Clinic fills a growing and vital need for low-barrier, patient-centered care.

Takeda TSE4502NYSETAK today announced that the U.S. Food and Drug Administration FDA has approved GAMMAGARD LIQUID Immune Globulin Infusion Human 10 solution as an intravenous immunoglobulin IVIG therapy to improve neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy CIDP.

New Indication Delivers on Takeda’s Commitment to Expanding its Broad and Diverse Immunoglobulin Portfolio to Meet the Needs of People Living with CIDP Approval Supported by Phase 3...